bpc 157 tb 500 ghk cu 30mg glow blend (BPC-157/TB-500/GHK-Cu) — IVs in the Keys GLOW BLEND Peptide (70mg) |

Relative weight: 1.8948 MDC: 07 DRG 442 - Disorders of the liver (except malignancy, Cirrhosis, or alcoholic hepatitis) with complications or comorbidities (CC)

PMID 10448523

Certain groups should exercise caution or avoid MIC injections, including individuals with heart conditions, pregnant or breastfeeding women, and those with liver disease, kidney problems, or metabolic disorders

Mechanisms studied in BPC-157 research include angiogenesis pathways, growth factor expression related to tissue repair, inflammatory response modulation, and GI tract cellular protection

SWITCHED OVER

We assess your hormone levels, health history, and specific goals before recommending a sermorelin therapy or CJC-1295 protocol